Fresenius Medical Care AG (ETR:FME)
Germany flag Germany · Delayed Price · Currency is EUR
40.81
+0.09 (0.22%)
Nov 11, 2026, 5:35 PM CET

Fresenius Medical Care AG Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Fresenius Medical Care AG stock has a consensus rating of "Hold" and an average price target of €40.29. The average 1-year stock price forecast is 1.27% lower than the current stock price, while the lowest is €29.00 (-28.94%) and the highest is €62.00 (+51.92%).

Price Target: €40.29 (-1.27%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price€29.00€40.29€39.30€62.00
Change-28.94%-1.27%-3.70%+51.92%

Analyst Ratings

The average analyst rating for Fresenius Medical Care AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy443232
Buy111112
Hold667876
Sell233333
Strong Sell333333
Total161717171716

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Sell
Maintains
€30.00 → €28.00
SellMaintains€30.00 → €28.00-31.39%Nov 10, 2026
Barclays
Barclays
Sell
Downgrades
€44.50 → €35.00
SellDowngrades€44.50 → €35.00-14.24%Nov 9, 2026
Goldman Sachs
Goldman Sachs
Hold
Maintains
€38.00 → €37.50
HoldMaintains€38.00 → €37.50-8.11%Nov 9, 2026
Unknown Analyst
DZ BANK AG
No rating
DZ BANK AG
Buy
Maintains
n/a
BuyMaintainsn/an/aNov 9, 2026
Bank of America Securities
Bank of America Securities
Sell
Reiterates
€32.00
SellReiterates€32.00-21.59%Nov 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
19.48B
from 19.63B
Decreased by -0.75%
Revenue Next Year
20.11B
from 19.48B
Increased by 3.22%
EPS This Year
4.06
from 4.28
Decreased by -5.13%
EPS Next Year
3.89
from 4.06
Decreased by -4.15%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
17.62B19.40B19.45B19.34B19.63B19.48B
Revenue Growth
-1.35%10.10%0.29%-0.61%1.51%-0.75%
Gross Profit
4.77B4.89B4.93B4.76B5.03B4.93B
Gross Margin
27.09%25.23%25.32%24.60%25.62%25.29%
Operating Income
1.90B1.54B1.52B1.54B1.87B1.82B
Net Income
969.31M673.41M499.00M537.91M978.37M711.02M
EPS
----4.284.06
EPS Growth
----37.62%-5.13%
Forward PE
14.7210.9213.7413.4514.0810.05
Dividend / Share
1.351.121.191.441.491.42
Dividend Growth
0.75%-17.04%6.25%21.01%3.47%-4.55%
Free Cash Flow
----1.78B1.56B
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High20.2B
Avg19.5B
Low19.1B

Revenue Growth

Revenue Growth202620272028
High
2.7%
Avg
-0.7%
Low
-2.4%

EPS Forecast

EPS202620272028
High4.29
Avg4.06
Low3.82

EPS Growth

EPS Growth202620272028
High
0.2%
Avg
-5.1%
Low
-10.7%